The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol
NCT00438789
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
Hemoglobinuria, Paroxysmal
Interventions
DRUG:
eculizumab
Sponsor
Alexion Pharmaceuticals, Inc.